Inactivity-induced diaphragm dysfunction and mitochondria-targeted antioxidants: new concepts in critical care medicine.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.Molecular and cellular biochemistry · 2021
   Review
2. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.British journal of pharmacology · 2014
   Review
3. High tidal volume mechanical ventilation elicits increased activity in protein kinase B and c-Jun NH2-terminal kinase pathways in mouse diaphragm.Intensive care medicine · 2011
   Article

Corrections and comments

• Comment on
  Mitochondria-targeted antioxidants protect against mechanical ventilation-induced diaphragm weakness.2011

Authors and funding

4 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as